Vertex Announce Licensing Agreement And Collaboration With Treefrog Therapeutics To Optimize Production Of Vertex's Cell Therapies For Type 1 Diabetes
Vertex Announce Licensing Agreement And Collaboration With Treefrog Therapeutics To Optimize Production Of Vertex's Cell Therapies For Type 1 Diabetes
Vertex 宣佈許可協議並與 Treefrog Therapeutics 合作，以優化 Vertex 的 1 型糖尿病細胞療法的生產
- Vertex obtains an exclusive license to TreeFrog's C-StemTM manufacturing technology in type 1 diabetes
- TreeFrog and Vertex to collaborate on scale-up of fully differentiated, insulin-producing pancreatic islet cells
- Vertex 獲得 TreeFrog 的 c-stemTM 製造技術的獨家許可，用於治療 1 型糖尿病
- TreeFrog 和 Vertex 將合作擴大完全分化、產生胰島素的胰島細胞
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。